ARAVIVE INC's ticker is ARAV and the CUSIP is 03890D108. A total of 37 filers reported holding ARAVIVE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46 | -89.4% | 346 | 0.0% | 0.00% | – |
| Q2 2023 | $436 | -37.0% | 346 | 0.0% | 0.00% | – |
| Q1 2023 | $692 | +51.4% | 346 | 0.0% | 0.00% | – |
| Q4 2022 | $457 | -99.8% | 346 | 0.0% | 0.00% | – |
| Q3 2022 | $283,000 | -17.3% | 346 | 0.0% | 0.00% | – |
| Q2 2022 | $342,000 | -48.8% | 346 | 0.0% | 0.00% | – |
| Q1 2022 | $668,000 | -12.3% | 346 | -0.6% | 0.00% | – |
| Q4 2021 | $762,000 | -43.3% | 348 | -3.6% | 0.00% | – |
| Q3 2021 | $1,343,000 | -37.8% | 361 | 0.0% | 0.00% | – |
| Q2 2021 | $2,159,000 | -78.8% | 361 | -76.6% | 0.00% | – |
| Q1 2021 | $10,188,000 | -30.7% | 1,546 | -40.7% | 0.00% | – |
| Q4 2020 | $14,703,000 | -11.1% | 2,607 | -25.9% | 0.00% | – |
| Q3 2020 | $16,535,000 | +210.2% | 3,518 | +668.1% | 0.00% | – |
| Q2 2020 | $5,331,000 | +4790.8% | 458 | +2310.5% | 0.00% | – |
| Q1 2020 | $109,000 | -58.1% | 19 | 0.0% | 0.00% | – |
| Q4 2019 | $260,000 | -75.4% | 19 | -86.5% | 0.00% | – |
| Q3 2019 | $1,058,000 | +25.1% | 141 | 0.0% | 0.00% | – |
| Q2 2019 | $846,000 | – | 141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 576,066 | $3,318,000 | 1.91% |
| New Leaf Venture Partners, L.L.C. | 946,423 | $5,451,000 | 1.63% |
| Artal Group S.A. | 1,450,000 | $8,352,000 | 0.35% |
| Alpine Global Management, LLC | 155,193 | $894,000 | 0.19% |
| Sio Capital Management, LLC | 76,514 | $441,000 | 0.15% |
| Baker Brothers Advisors | 486,333 | $2,801,000 | 0.02% |
| WEDBUSH SECURITIES INC | 15,900 | $92,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 128,365 | $739,000 | 0.01% |
| TWO SIGMA ADVISERS, LP | 160,325 | $923,000 | 0.00% |
| Renaissance Technologies | 541,281 | $3,118,000 | 0.00% |